- Home/
- Article /
- Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy.
Full Author : ['Akhtar, Md Sayeed', 'Pillai, Krishna Kolappa', 'Hassan, Quamrul', 'Ansari, Shahid Husain', 'Ali, Javed', 'Akhtar, Mohammed', 'Najmi, Abul Kalam']
Journal Title : Clinical and experimental hypertension (New York, N.Y. : 1993)
Chapter : Section3
Journal Year : 2016
Cited by : Not Available
Diabetic cardiomyopathy plays a major role in morbidity and mortality among cardiovascular disorder-related complications. This study was designed to explore long-term benefits of Levosimendan (LEVO) along with Ramipril and Insulin. Diabetic cardiomyopath.....
Keywords : ["levosimendan suppresses oxidative injury apoptotic signaling", "streptozotocininduce diabetic cardiomyopathy", "mitochondrial degeneration"]